inner-banner-bg

Stem Cell Research International(SCRI)

ISSN: 2639-6866 | DOI: 10.33140/SCRI

Impact Factor: 1.12

Safety of Allogeneic Mesenchymal Stromal Cell Therapy Across Human Clinical Indications: A Systematic Review of Landmark Clinical Trials and Published Safety Evidence

Citation

Kirk Sanford*, Felix Porras, Fergie Martinez, Hugo Ramos, Janine Zamitiz, Carlos Green and Edward Ramsay

Sanford, K., Porras, F., Martinez, F., Ramos, H., Zamitiz, J., et al. (2026). Safety of Allogeneic Mesenchymal Stromal Cell Therapy Across Human Clinical Indications: A Systematic Review of Landmark Clinical Trials and Published Safety Evidence. Stem Cell Res Int, 10(1), 01-09.

Abstract HTML PDF